Subscribe

Medicine Man Technologies, Inc. (SHWZ)

USD0.00 +0.00 (+0.00%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address 4880 Havana Street 80239
Denver, CO, US
CEO Forrest Hoffmaster
IPO 2018-02-16
CIK 1622879 ISIN US58468U1060

Explore sections of this company profile

Also trades on CBOE CA · SHWZ.NE (CAD) Other OTC · SHWZ (USD)
Description

Schwazze, formally known as Medicine Man Technologies, Inc., functions as a prominent cannabis enterprise. Its operations are structured across three primary divisions: Retail, Wholesale, and Other segments. The company offers a diverse product portfolio encompassing a comprehensive array of cannabis goods. This includes unprocessed flower, various concentrates, edible products, pre-rolled joints, topical applications, and other associated items, alongside vape cartridges and syringes. As of March 14, 2022, Schwazze managed a significant retail network. This consisted of 23 recreational cannabis dispensaries located throughout Denver and the wider Colorado region, operating under recognizable brand names such as Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift. Additionally, it operated 10 medical cannabis dispensaries in New Mexico, primarily recognized by the R. Greenleaf banner. Beyond its core product and retail ventures, Schwazze extends its services to include licensing, consulting, and expertise in facility design and management. It is also responsible for publishing the "Three A Light" guide. Furthermore, the company is engaged in the manufacturing, wholesale distribution, and retail sale of various plant nutrients specifically formulated for cannabis cultivation, complementing this with the provision of hydroponic and indoor gardening supplies. Established in 2014, the firm maintains its corporate headquarters in Denver, Colorado.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
7
Beta
1.32
Float Shares
67.06M
Free Float %
83.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +0.00% -99.55% -99.55% +900.00% -99.95% -100.00% -100.00% -100.00% -100.00%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (1 ratings, all time) Buy
Price Targets & DCF
Current price
0.00
Ratings Trend (MoM) 100% Bullish
Rating 2025-09 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
-0.16
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
2 / 10
No MOAT
Operational MOAT
✗ Below peers
  • Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%
    +8.2% Q2'24: +2.0% (vs Q2'23)
  • EPS growth Drug Manufacturers - Specialty & Generic: +16.5%
    +46.9% Q2'24: -81.8% (vs Q2'23)
  • FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%
    -5.6% Q2'24: -1.7% (vs Q2'23)
  • EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%
    +10.0% Q2'24: -6.3% (vs Q2'23)
  • ROIC Drug Manufacturers - Specialty & Generic: +6.5%
    +5.9% Q2'24: -4.0% (vs Q2'23)
  • Share dilution Drug Manufacturers - Specialty & Generic: +0.0%
    +20.3% Q2'24: +30.6% (vs Q2'23)
  • Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×
    5.02× Q2'24: 11.70× (vs Q2'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.32) × ERP
WACC = 0% × Ke + 100% × Kd (16.7%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2020
actual
Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Revenue
24.00M
est: 24.15M (-0.6%)
108.42M
est: 112.70M (-3.8%)
159.38M
est: 159.76M (-0.2%)
172.45M
est: 174.05M (-0.9%)
174.80M
est.
195.00M
est.
EBITDA
-19.80M
est: -5.05M (-291.9%)
34.51M
est: -23.58M (+246.4%)
38.12M
est: -33.42M (+214.1%)
38.19M
est: -36.41M (+204.9%)
-36.57M
est.
-40.79M
est.
EBIT
-20.27M
est: -6.47M (-213.5%)
25.93M
est: -30.18M (+185.9%)
26.57M
est: -42.78M (+162.1%)
17.26M
est: -46.60M (+137.0%)
-46.80M
est.
-52.21M
est.
Net Income
-19.42M
est: -21.30M (+8.8%)
14.52M
est: 5.49M (+164.7%)
-18.47M
est: 3.23M (-672.3%)
-34.55M
-53.56M
est.
-38.72M
est.
SGA
29.68M
est: 18.98M (+56.3%)
38.94M
est: 88.60M (-56.0%)
59.42M
est: 125.59M (-52.7%)
70.93M
est: 136.82M (-48.2%)
137.41M
est.
153.29M
est.
EPS
-0.47
est: -0.33 (-42.4%)
0.17
est: 0.09 (+100.0%)
-0.49
est: 0.05 (-1,080.0%)
-0.26
-0.83
est.
-0.60
est.

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
1.08M
OE per share TTM
0.01
Owner's Yield
136,923.18%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
27.8%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
1
Total invested
28.00
Insider transactions (90d)
0
Beneficial owners (>5%)
6
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 6.38%4 26.99M 6.38% 26.99M 26.99M IN United States 2021-07-02
2 6.38%2 26.99M 6.38% 26.99M 26.99M IN United States 2021-07-02
3 CRW Capital Cann Holdings, LLC 21.13M 33.20% 21.13M 10.00 OO Delaware 2021-03-09
4 CRW Capital, LLC 21.13M 33.20% 21.13M 10.00 OO Delaware 2021-03-09
5 Jeffrey A. Cozad 21.13M 33.20% 21.13M 10.00 IN United States 2021-03-09
6 Marc R. Rubin 21.13M 33.20% 21.13M 10.00 IN United States 2021-03-09

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2025 Q3
Investors holding
1
+0 vs prev Q
New positions
0
Closed positions
0
Increased
0
Reduced
0
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 NORTH STAR ASSET MANAGEMENT INC -281.7K (-100.0%) -28.0 (-100.0%) 0.00% -0.356 pp 0.00% +0.000 pp USD 37 qtrs SOLD
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
1.67
Bullish
Buys
1
Sells
1
Shares acquired
500.0K
Shares disposed
300.0K
Cash buys
1.00
Cash sales
Net activity
+200,000
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2025-12-05 JONES CHRISTINE Officer D-Return D Employee Stock Option (Right to Buy) 300,000 1.31 393.0K 0 D
2024-06-28 VRABECK KATHY P Director A-Award A Common Stock 67,308 0.00 127,266
2024-06-28 Stewart Brad Director A-Award A Common Stock 72,436 0.00 215,895
2024-06-28 Rubin Marc R Director / 10% Owner A-Award A Common Stock 67,308 0.00 244,776
2024-06-28 Mukharji Pratap Chandra Director A-Award A Common Stock 67,308 0.00 314,323
2024-06-28 Montalbano Paul Joseph Director A-Award A Common Stock 67,308 0.00 320,728
2024-06-28 Dye Justin Director / 10% Owner A-Award A Common Stock 192,308 0.00 2,023,287
2024-06-28 Cozad Jeffrey Alley Director / 10% Owner A-Award A Common Stock 70,513 0.00 322,131
2024-06-28 Berger Jonathan W Director A-Award A Common Stock 139,103 0.00 587,980
2024-05-03 Pabon Daniel Officer F-InKind D Common Stock 5,166 0.62 3.2K 10,154
2024-05-03 JONES CHRISTINE Officer F-InKind D Common Stock 4,648 0.62 2.9K 13,360
2024-05-03 HOFFMASTER FORREST Officer A-Award A Common Stock 18,204 0.00 43,204
2024-04-11 Pabon Daniel Officer P-Purchase A Common Stock 150 0.70 105.00 150
2024-03-29 VRABECK KATHY P Director A-Award A Common Stock 32,012 0.00 59,958
2024-03-29 Stewart Brad Director A-Award A Common Stock 34,451 0.00 143,459
2024-03-29 Rubin Marc R Director / 10% Owner A-Award A Common Stock 32,012 0.00 177,468
2024-03-29 Mukharji Pratap Chandra Director A-Award A Common Stock 32,012 0.00 247,015
2024-03-29 Montalbano Paul Joseph Director A-Award A Common Stock 32,012 0.00 253,420
2024-03-29 Dye Justin Director / 10% Owner A-Award A Common Stock 91,463 0.00 1,830,979
2024-03-29 Cozad Jeffrey Alley Director / 10% Owner A-Award A Common Stock 33,537 0.00 251,618
2024-03-29 Berger Jonathan W Director A-Award A Common Stock 66,159 0.00 448,877
2023-12-29 VRABECK KATHY P Director A-Award A Common Stock 27,946 0.00 27,946
2023-12-29 Stewart Brad Director A-Award A Common Stock 46,388 0.00 108,908
2023-12-29 Rubin Marc R Director / 10% Owner A-Award A Common Stock 43,103 0.00 145,456
2023-12-29 Mukharji Pratap Chandra Director A-Award A Common Stock 43,103 0.00 215,003
2023-12-29 Montalbano Paul Joseph Director A-Award A Common Stock 43,103 0.00 221,408
2023-12-29 Garwood Jeff Director P-Purchase A Common Stock 15,158 0.00 490,093
2023-12-29 Dye Justin Director / 10% Owner A-Award A Common Stock 123,153 0.00 1,739,516
2023-12-29 Cozad Jeffrey Alley Director / 10% Owner A-Award A Common Stock 45,156 0.00 218,081
2023-12-29 Berger Jonathan W Director A-Award A Common Stock 89,080 0.00 382,718
2023-12-05 JONES CHRISTINE Officer P-Purchase A Common Stock 1,880 0.56 1.0K 4,355
2023-11-29 Krishnamurthy Nirup Director / Officer P-Purchase A Common Stock 6,600 0.59 3.9K 1,616,600
2023-11-29 HOFFMASTER FORREST Officer P-Purchase A Common Stock 9,088 0.58 5.3K 25,000
2023-11-27 JONES CHRISTINE Officer P-Purchase A Common Stock 2,475 0.60 1.5K 2,475
2023-11-27 HOFFMASTER FORREST Officer P-Purchase A Common Stock 8,000 0.59 4.7K 15,912
2023-11-21 Krishnamurthy Nirup Director / Officer P-Purchase A Common Stock 10,000 0.61 6.1K 1,610,000
2023-11-21 HOFFMASTER FORREST Officer P-Purchase A Common Stock 7,912 0.58 4.6K 7,912
2023-11-02 VRABECK KATHY P Director 0 0.00 0
2023-09-29 Stewart Brad Director A-Award A Common Stock 34,870 0.00 62,520
2023-09-29 Rubin Marc R Director / 10% Owner A-Award A Common Stock 33,228 0.00 102,353
2023-09-29 Mukharji Pratap Chandra Director A-Award A Common Stock 33,228 0.00 171,900
2023-09-29 Montalbano Paul Joseph Director A-Award A Common Stock 33,228 0.00 178,305
2023-09-29 Garwood Jeff Director P-Purchase A Common Stock 22,152 0.00 474,935
2023-09-29 Dye Justin Director / 10% Owner A-Award A Common Stock 130,801 0.00 1,998,863
2023-09-29 Cozad Jeffrey Alley Director / 10% Owner A-Award A Common Stock 34,253 0.00 172,925
2023-09-29 Berger Jonathan W Director A-Award A Common Stock 40,900 0.00 293,638
2023-08-28 Garwood Jeff Director P-Purchase A Common Stock 5,300 0.65 3.4K 418,083
2023-08-25 Rubin Marc R Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 500 1.20 600.00 31,950
2023-08-25 Cozad Jeffrey Alley Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 500 1.20 600.00 31,950
2023-08-25 CRW Capital, LLC 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 500 1.20 600.00 31,950
2023-08-16 Garwood Jeff Director P-Purchase A Common Stock 25,000 0.75 18.8K 402,783
2023-08-15 Garwood Jeff Director P-Purchase A Common Stock 10,155 0.74 7.5K 369,783
2023-05-24 Krishnamurthy Nirup Director / Officer A-Award A Employee Stock Option (Right to Buy) 800,000 1.04 828.0K 2,000,000
2023-05-16 Dye Justin Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 140 1.20 168.00 445
2023-05-15 Dye Justin Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 122 1.20 146.40 305
2023-05-03 Wahdan Salim Husan Director A-Award A Common Stock 10,892 0.00 76,464
2023-05-03 Stewart Brad Director A-Award A Common Stock 13,825 0.00 27,650
2023-05-03 Pabon Daniel Officer A-Award A Stock Option (Right to Buy) 88,214 1.03 90.9K 88,214
2023-05-03 Krishnamurthy Nirup Director / Officer A-Award A Stock Option (Right to Buy) 335,213 1.03 345.3K 335,213
2023-05-03 JONES CHRISTINE Officer A-Award A Stock Option (Right to Buy) 79,392 1.03 81.8K 79,392
2023-05-03 HOFFMASTER FORREST Officer A-Award A Stock Option (Right to Buy) 105,857 1.03 109.0K 105,857
2023-05-03 Berger Jonathan W Director A-Award A Common Stock 12,136 0.00 252,738
2023-04-11 Wahdan Salim Husan Director A-Award A Common Stock 10,892 0.00 65,572
2023-04-11 Stewart Brad Director A-Award A Common Stock 13,825 0.00 13,825
2023-04-11 Rubin Marc R Director / 10% Owner A-Award A Common Stock 69,125 0.00 69,125
2023-04-11 Mukharji Pratap Chandra Director A-Award A Common Stock 50,971 0.00 138,672
2023-04-11 Montalbano Paul Joseph Director A-Award A Common Stock 50,971 0.00 145,077
2023-04-11 Garwood Jeff Director A-Award A Common Stock 50,971 0.00 324,628
2023-04-11 Cozad Jeffrey Alley Director / 10% Owner A-Award A Common Stock 50,971 0.00 138,672
2023-04-11 Berger Jonathan W Director A-Award A Common Stock 50,971 0.00 240,602
2023-04-07 Rubin Marc R Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 8,290 1.20 9.9K 39,740
2023-04-07 Cozad Jeffrey Alley Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 8,290 1.20 9.9K 39,740
2023-04-07 CRW Capital, LLC 10% Owner P-Purchase A Right to Buy Series A Cumulative Convertible Preferred Stock 8,290 1.20 9.9K 39,740
2023-03-23 Stewart Brad Director 0 0.00 0
2023-02-15 JONES CHRISTINE Officer D Employee Stock Option (Right to Buy) 300,000 1.31 393.0K 0
2023-02-13 Dye Justin Director / Officer / 10% Owner P-Purchase A Common Stock 500,000 1.50 750.0K 1,868,062
2023-01-16 HOFFMASTER FORREST Officer 0 0.00 0
2022-11-30 Ruden Brian Director S-Sale D Series A Cumulative Convertible Preferred Stock 1,781 1,000.00 1.78M 5,646
2022-11-30 Rubin Marc R Director P-Purchase A Right to Buy Series A Cumulative Convertible Preferred Stock 10,390 1,000.00 10.39M 39,740
2022-11-30 Cozad Jeffrey Alley Director P-Purchase A Right to Buy Series A Cumulative Convertible Preferred Stock 10,390 1,000.00 10.39M 39,740
2022-11-30 CRW Capital, LLC Director P-Purchase A Right to Buy Series A Cumulative Convertible Preferred Stock 10,390 1,000.00 10.39M 39,740
2022-11-30 CRW Capital Holdings II, LLC Director D Right to Buy Series A Cumulative Convertible Preferred Stock 10,076,222 1.20 12.09M
2022-11-23 Dye Justin Officer A-Award A Common Stock 509,700 2.00 1.02M 1,368,062
2022-11-21 Dye Justin Officer A-Award A Common Stock 175,000 1.82 318.5K 858,362
2022-11-18 Dye Justin Officer A-Award A Common Stock 178,620 1.70 303.7K 683,362
2022-11-17 Dye Justin Officer A-Award A Common Stock 26,290 1.72 45.2K 504,742
2022-11-16 Dye Justin Officer A-Award A Common Stock 106,500 1.80 191.7K 584,952
2022-11-15 Dye Justin Officer A-Award A Common Stock 187,484 1.57 294.3K 478,452
2022-11-14 Dye Justin Officer A-Award A Common Stock 142,258 1.31 186.4K 290,968
2022-10-28 Rubin Marc Director I 13% Senior Convertible Note Due 2026 0 0.00
2022-10-12 Krishnamurthy Nirup Director / Officer A-Award A Employee Stock Option (Right to Buy) 200,000 1.24 248.0K 200,000
2022-09-22 Berger Jonathan W Director A-Award A Common Stock 102,355 0.00 189,631
2022-08-22 Garwood Jeff Director P-Purchase A Common Stock 1,500 1.37 2.1K 273,657
2022-08-18 Garwood Jeff Director P-Purchase A Common Stock 945 1.42 1.3K 265,758
2022-06-24 Wahdan Salim Husan Director A-Award A Common Stock 30,170 0.00 54,680
2022-06-24 Berger Jonathan W Director A-Award A Common Stock 19,085 0.00 87,276
2022-06-14 Mukharji Pratap Chandra Director D-Return D Employee Stock Option (Right to Buy) 20,349 0.00 0
2022-06-14 Montalbano Paul Joseph Director A-Award A Common Stock 22,728 0.00 94,106
2022-06-14 Garwood Jeff Director D-Return D Employee Stock Option (Right to Buy) 20,349 0.00 0
2022-06-14 Cozad Jeffrey Alley Director / 10% Owner D-Return D Employee Stock Option (Right to Buy) 20,349 1.72 35.0K 0
2022-06-14 Berger Jonathan W Director D-Return D Employee Stock Option (Right to Buy) 20,349 0.00 0
2022-05-04 Mukharji Pratap Chandra Director A-Award A Common Stock 40,463 0.00 64,973
2022-05-04 Montalbano Paul Joseph Director A-Award A Common Stock 40,463 0.00 71,378
2022-05-04 Garwood Jeff Director A-Award A Employee Stock Option (Right to Buy) 20,349 0.00 20,349
2022-05-04 Cozad Jeffrey Alley Director A-Award A Employee Stock Option (Right to Buy) 20,349 1.72 35.0K 20,349
2022-05-04 Berger Jonathan W Director A-Award A Employee Stock Option (Right to Buy) 20,349 0.00 20,349
2022-04-18 Garwood Jeff Director P-Purchase A Common Stock 19,304 1.82 35.1K 192,735
2022-04-13 Garwood Jeff Director P-Purchase A Common Stock 8,000 2.06 16.5K 160,735
2022-04-12 Garwood Jeff Director P-Purchase A Common Stock 10,000 2.10 21.0K 152,735
2022-04-11 Garwood Jeff Director P-Purchase A Common Stock 15,000 2.11 31.6K 142,735
2022-04-07 Garwood Jeff Director P-Purchase A Common Stock 1,500 2.04 3.1K 114,235
2022-04-06 Garwood Jeff Director P-Purchase A Common Stock 5,000 2.08 10.4K 112,735
2022-02-09 Mukharji Pratap Chandra Director D 13% Senior Convertible Note Due 2026 90,049 2.24 201.7K 0
2022-02-09 Montalbano Paul Joseph Director D Common Stock 0 0.00 30,915
2021-12-13 Berger Jonathan W Director D Common Stock 0 0.00 5,000
2021-12-07 Rubin Marc R Director I 13% Senior Convertible Note Due 2026 100,000 2.24 224.0K
2021-12-07 Rubin Marc Director I 13% Senior Convertible Note Due 2026 100,000 2.24 224.0K
2021-12-07 Mukharji Pratap Chandra Director A-Award A 13% Senior Convertible Note Due 2026 200,000 2.24 448.0K 200,000
2021-12-07 Garwood Jeff Director A-Award A 13% Senior Convertible Note Due 2026 300,000 2.24 672.0K 300,000
2021-12-07 Cozad Jeffrey Alley Director / 10% Owner A-Award A 13% Senior Convertible Note Due 2026 250,000 2.24 560.0K 250,000
2021-03-30 Dye Capital Cann Holdings, II Director P-Purchase A Series A Cumulative Convertible Preferred Stock 4,000 1.20 4.8K 21,350
2021-03-25 Wahdan Salim Husan Director A-Award A Common Stock 24,510 0.00 24,510
2021-03-25 Mukharji Pratap Chandra Director A-Award A Common Stock 24,510 0.00 24,510
2021-03-25 Garwood Jeff Director A-Award A Common Stock 24,210 0.00 89,510
2021-03-25 Cozad Jeffrey Alley Director / 10% Owner A-Award A Common Stock 24,510 0.00 24,510
2021-03-14 Wahdan Salim Husan Director D Series A Cumulative Convertible Preferred Stock 365,000 1.20 438.0K 0
2021-03-03 Cozad Jeffrey Alley 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 2,100 1.20 2.5K 25,350
2021-03-03 CRW Capital, LLC 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 2,100 1.20 2.5K 25,350
2021-03-02 Wahdan Salim Husan Director D Warrants (Right to Buy) 23,759 1.20 28.5K 0
2021-03-02 Ruden Brian Director A-Award A Warrant (Right to Buy) 1,077,331 1.20 1.29M 1,077,331
2021-03-02 Joudeh Naser Ahmad A-Award A Warrant (Right to Buy) 162,044 1.20 194.5K 264,592
2021-03-02 Dye Capital Cann Holdings, II Director P-Purchase A Series A Cumulative Convertible Preferred Stock 2,500 1.20 3.0K 17,350
2021-02-26 Dye Justin Director / 10% Owner A-Award A Series A Cumulative Convertible Preferred Stock 5,060 1.20 6.1K 5,060
2021-02-26 Dye Capital & Co LLC Director C-Conversion A Convertible Note 5,060 1.20 6.1K 5,060
2021-02-26 Cozad Jeffrey Alley 10% Owner I Series A Cumulative Convertible Preferred Stock 19,375,000 1.20 23.25M 0
2021-02-26 CRW Capital, LLC 10% Owner I Series A Cumulative Convertible Preferred Stock 19,375,000 1.20 23.25M 0
2021-02-25 Dye Capital Cann Holdings, II Director P-Purchase A Series A Cumulative Convertible Preferred Stock 1,300 1.20 1.6K 14,850
2021-02-03 Ruden Brian Director A-Award A Warrant (Right to Buy) 113,211 1.20 135.9K 113,211
2021-02-03 Dye Capital Cann Holdings, II Director P-Purchase A Series A Cumulative Convertible Preferred Stock 3,100 1.20 3.7K 13,550
2021-01-27 Mukharji Pratap Chandra Director I Common Stock 0 0.00 39,683
2020-12-22 Dye Justin Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 1,300 1.20 1.6K 10,450
2020-12-22 Dye Capital Cann Holdings, II Director P-Purchase A Series A Cumulative Convertible Preferred Stock 1,300 1.20 1.6K 10,450
2020-12-18 Ruden Brian Director A-Award A Warrant (Right to Buy) 257,036 1.20 308.4K 257,036
2020-12-18 Dye Justin Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 1,450 1.20 1.7K 9,150
2020-12-18 Dye Capital Cann Holdings, II Director P-Purchase A Series A Cumulative Convertible Preferred Stock 1,450 1.20 1.7K 9,150
2020-12-17 Ruden Brian Director A-Award A Series A Cumulative Convertible Preferred Stock 1,431 1.20 1.7K 1,431
2020-12-17 Joudeh Naser Ahmad D Series A Cumulative Convertible Preferred Stock 198,333 1.20 238.0K 0
2020-12-16 Dye Justin Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 7,700 1.20 9.2K 7,700
2020-12-16 Dye Capital Cann Holdings, II Director P-Purchase A Series A Cumulative Convertible Preferred Stock 7,700 1.20 9.2K 7,700
2020-12-16 Dye Capital & Co LLC Director P-Purchase A Convertible Note 5,000,000 0.00 0
2020-12-15 Pabon Daniel Officer D-Return D Employee Stock Option (Right to Buy) 550,000 2.85 1.57M 0
2020-12-15 Krishnamurthy Nirup Officer A-Award A Employee Stock Option (Right to Buy) 400,000 1.26 504.0K 400,000
2020-12-15 Huber Nancy B Officer D-Return D Employee Stock Option (Right to Buy) 50,000 3.17 158.5K 0
2020-11-20 Garwood Jeff Director A-Award A Common Stock 42,735 0.00 107,735
2020-10-08 Garwood Jeff Director P-Purchase A Common Stock 111 1.15 127.65 65,000
2020-10-01 Ruden Brian Director A-Award A Common Stock 42,735 0.00 42,735
2020-10-01 Riera Leonardo Director A-Award A Employee Stock Option (Right to Buy) 325,000 1.17 380.3K 325,000
2020-10-01 Dye Justin Director / 10% Owner A-Award A Common Stock 42,735 0.00 80,355
2020-09-09 Krishnamurthy Nirup Officer D Options 300,000 1.78 534.0K 0
2020-09-09 Garwood Jeff Director D Common Stock 0 0.00 64,889
2020-05-20 Dye Justin Director / Officer / 10% Owner P-Purchase A Warrant to purchase common stock 187,500 3.50 656.3K 9,287,500
2020-04-20 Riera Leonardo Director A-Award A Employee Stock Option (Right to Buy) 220,000 1.71 376.2K 220,000
2020-03-30 Dye Justin Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 4,000 1.20 4.8K 21,350
2020-03-27 Pabon Daniel Officer A-Award A Employee Stock Option (Right to Buy) 100,000 1.52 152.0K 100,000
2020-03-27 Huber Nancy B Officer A-Award A Employee Stock Option (Right to Buy) 100,000 1.52 152.0K 100,000
2020-03-02 Dye Justin Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 2,500 1.20 3.0K 17,350
2020-02-25 Dye Justin Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 1,300 1.20 1.6K 14,850
2020-02-03 Dye Justin Director / 10% Owner P-Purchase A Series A Cumulative Convertible Preferred Stock 3,100 1.20 3.7K 13,550
2019-12-15 Dye Justin Director / 10% Owner A-Award A Employee Stock Option (Right to Buy) 2,000,000 1.26 2.52M 2,000,000
2019-12-10 Ruden Brian Director 0 0.00 0
2019-12-05 Pabon Daniel Officer A-Award A Employee Stock Option (Right to Buy) 550,000 2.85 1.57M 550,000
2019-12-05 Huber Nancy B Officer A-Award A Employee Stock Option (Right to Buy) 550,000 2.88 1.58M 550,000
2019-12-05 Dye Justin Director / 10% Owner A-Award A Employee Stock Option (Right to Buy) 2,000,000 2.88 5.76M 2,000,000
2019-06-19 Dickman Paul Director S-Sale D Common Stock 5,090 3.91 19.9K 1,275,053
2019-06-18 Dickman Paul Director S-Sale D Common Stock 74,465 3.92 291.9K 1,280,143
2019-06-17 Dickman Paul Director S-Sale D Common Stock 10,192 3.95 40.3K 1,354,608
2019-06-16 Dye Justin Director / 10% Owner P-Purchase A Common Stock 3,500,000 2.00 7.00M 5,000,000
2019-06-05 Riera Leonardo Director 0 0.00 0
2019-06-05 Dye Justin Director A-Award A Option to purchase common stock 300,000 3.72 1.12M 300,000
2019-06-05 DeGabrielle Robert R. Director 0 0.00 0
2019-03-28 Haupt Charles N. Director S-Sale D Common Stock 30,000 1.25 37.5K 45,000
2019-03-26 Sandberg Jonathan Officer S-Sale D Common Stock 45,500 2.07 94.0K 0
2019-03-25 Sandberg Jonathan Officer S-Sale D Common Stock 13,000 2.04 26.5K 45,500
2019-03-25 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 200,000 1.50 300.0K 3,620,556
2019-03-22 Sandberg Jonathan Officer S-Sale D Common Stock 1,500 2.02 3.0K 58,500
2019-03-15 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 37,689 1.81 68.2K 4,020,556
2019-03-14 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 62,770 1.82 114.0K 4,058,245
2019-03-13 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 41,498 1.84 76.2K 4,121,015
2019-03-12 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 1,400 1.82 2.6K 4,162,513
2019-03-11 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 4,702 1.84 8.6K 4,163,913
2019-03-08 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 200,000 1.00 200.0K 3,820,556
2019-03-07 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 42,681 1.87 79.6K 4,169,615
2019-03-06 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 8,260 1.86 15.4K 4,212,296
2019-02-20 Haupt Joshua Officer / 10% Owner S-Sale D Common Stock 200,000 1.35 270.0K 4,220,556
2019-01-17 Sandberg Jonathan Officer S-Sale D Common Stock 2,500 1.63 4.1K 0
2019-01-03 Williams Andrew Johns Director / Officer / 10% Owner S-Sale D Common Stock 229,000 1.00 229.0K 2,074,506
2018-12-05 PUGLISE JOSEPH P. Director / Officer D Stock Option (right to buy) 2,000,000 1.49 2.98M 0
2018-06-30 Haupt Charles N. Director A-Award A Common Stock 50,000 0.00 75,000
2018-06-29 Williams Andrew Johns Director S-Sale D Common Stock 6,830 1.42 9.7K 2,303,506
2018-06-28 Williams Andrew Johns Director S-Sale D Common Stock 8,266 1.44 11.9K 2,310,336

Executive team

Top executives
EBIT / Employee
23.7K
Shares Outstanding
80.16M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2023 Nirup Krishnamurthy, Chief Executive Officer 413.3K 100.0K 1.89M 813.7K 8.2K 3.22M 83.81%
2 2023 Forrest Hoffmaster Chief Financial Officer 289.6K 30.0K 75.0K 792.3K 7.9K 1.19M 72.59%
3 2023 Daniel Pabon, Chief Policy & Regulatory Affairs Officer 250.0K 30.0K 62.5K 62.5K 13.0K 418.0K 29.90%
4 2023 Justin Dye, Chief Executive Officer 148.1K 178.3K 326.4K 54.64%
5 2022 Nirup Krishnamurthy, Chief Executive Officer 305.1K 177.2K 886.00 483.2K 36.67%
6 2022 Nirup Krishnamurthy, President 305.1K 177.2K 886.00 483.2K 36.67%
7 2022 Justin Dye, Chief Executive Officer 350.0K 886.00 350.9K 0.00%
8 2022 Daniel Pabon, Chief Policy & Regulatory Affairs Officer 250.0K 30.0K 4.0K 284.0K 0.00%
9 2022 Daniel Pabon, Chief Government Affairs Officer 250.0K 30.0K 4.0K 284.0K 0.00%
10 2021 Justin Dye, Chief Executive Officer 350.0K 116.0K 466.0K 0.00%
11 2021 Nirup Krishnamurthy, President 301.4K 99.5K 400.9K 0.00%
12 2021 Nirup Krishnamurthy, Chief Executive Officer 301.4K 99.5K 400.9K 0.00%
13 2021 Nirup Krishnamurthy, Chief Operating Officer 301.4K 99.5K 400.9K 0.00%
14 2021 Daniel Pabon, General Counsel and Chief Government Affairs Officer 268.7K 84.4K 353.1K 0.00%
15 2021 Daniel Pabon, Chief Policy & Regulatory Affairs Officer 268.7K 84.4K 353.1K 0.00%
16 2021 Daniel Pabon, Chief Government Affairs Officer 268.7K 84.4K 353.1K 0.00%
17 2020 Nirup Krishnamurthy, Chief Operating Officer 218.3K 981.1K 1.20M 81.80%
18 2020 Justin Dye, Chief Executive Officer 311.5K 50.0K 304.0K 665.5K 53.19%
19 2020 Daniel Pabon, Chief Government Affairs Officer 228.5K 145.5K 374.0K 38.91%
20 2020 Daniel Pabon, General Counsel and Chief Government Affairs Officer 228.5K 145.5K 374.0K 38.91%
21 2020 Nancy Huber, Chief Financial Officer 207.7K 145.5K 353.2K 41.20%
22 2019 Justin Dye, Chief Executive Officer 128.1K 5.28M 5.41M 97.63%
23 2019 Joe Puglise, Former Chief Operating Officer 300.0K 100.0K 2.28M 2.68M 85.06%
24 2019 Nancy Huber, Chief Financial Officer 60.9K 1.44M 1.50M 95.94%
25 2019 Daniel Pabon, Chief Government Affairs Officer 76.2K 1.42M 1.50M 94.93%
26 2019 Paul Dickman, Former Chief Financial Officer 33.6K 100.0K 660.0K 109.3K 902.9K 73.10%
27 2019 Andrew Williams, Former Chief Executive Officer 302.3K 100.0K 6.0K 408.3K 0.00%
28 2018 Brett Roper, previous CEO 156.0K 75.0K 265.0K 496.0K 0.00%
29 2018 Joe Puglise, Former Chief Operating Officer 25.0K 325.3K 350.3K 92.86%
30 2018 Jonathan Sandberg, CFO 124.0K 140.4K 204.4K 0.00%
31 2018 Josh Haupt, CCO 156.0K 72.2K 12.0K 168.0K 0.00%
32 2018 Joe Puglise, COO 25.0K 250.0K 25.0K 1,000.00%
33 2018 Andrew Williams, Former Chief Executive Officer 25.0K 25.0K 0.00%
34 2018 Andy Williams, CEO 25.0K 25.0K 0.00%
35 2017 Paul Dickman, Director 57.0K 1.43M 1.48M 96.16%
36 2017 Brett Roper, previous CEO 156.0K 1.31M 1.00M 89.5K 1.05M 95.65%
37 2017 Andy Williams, CEO 1.01M 750.0K 632.0K 118.68%
38 2017 Paul Dickman, previous CFO 30.0K 325.0K 250.0K 230.0K 108.70%
39 2017 Joshua Haupt, CRO 120.0K 120.0K 0.00%
40 2017 Josh Haupt, CCO 120.0K 65.0K 120.0K 0.00%
41 2017 Jonathan Sandberg, CFO Andy Williams, Chairperson 62.0K 42.5K 104.5K 40.68%
42 2017 Jonathan Sandberg, CFO 62.0K 65.0K 102.0K 0.00%
43 2016 Paul Dickman, Chief Financial Officer 49.0K 154.4K 203.4K 75.91%
44 2016 Brett Roper, COO and Secretary 19.0K 119.6K 138.6K 86.29%
45 2015 Brett Roper, CEO and Secretary 12.0K 48.8K 60.8K 0.00%
46 2015 Brett Roper, COO and Secretary 12.0K 48.8K 60.8K 0.00%
47 2015 Jonathan Sandberg, CFO Andy Williams, Chairperson 12.0K 43.8K 55.8K 0.00%
48 2015 Andrew Williams, CEO and President 12.0K 43.8K 41.6K 0.00%
49 2015 Paul Dickman, Director 12.0K 10.3K 22.3K 46.07%
50 2015 Paul Dickman, Chief Financial Officer 12.0K 10.3K 22.3K 46.07%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2024-04-29 DEFA14A
2024-04-29 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2025-12-09 4
2025-11-18 15-12G
2025-10-14 8-K
2025-07-18 8-K
2025-05-06 8-K
2025-04-21 8-K
2025-04-01 NT 10-K
2025-03-13 8-K
2024-12-12 8-K
2024-12-04 8-K

Executive team

NameTitleCompensationGender
Forrest Hoffmaster Chief Executive Officer 343.2K male
Christopher Lee Driessen Executive Vice President of Commercial Sales male
Collin Lodge President of Colorado Division male
Dan Bonach Vice President of Human Resources male
David Kaufman Executive Vice President of Integrated Supply Chain male
Ed Eissenstat Vice President of Information Technology & C.I.O
Philippe Faraut Interim Chief Financial Officer male
Rebecca Terry Controller
Christine Jones Chief Legal Officer & Corporate Secretary female
Todd Williams Executive Vice President of M&A and Real Estate male
ESG Rating
B
DRUG MANUFACTURERS - SPECIALTY & GENERIC
2024
E (Environmental)
88.7 / 66.0
Company / Sector avg.
S (Social)
89.6 / 70.0
Company / Sector avg.
G (Governance)
65.5 / 66.6
Company / Sector avg.
ESG Total
81.3 / 67.5
Company / Sector avg.
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits